Zokinvy is the first and only treatment to target the cause and symptoms of progeria, also known as Hutchinson-Gilford progeria syndrome, and processing-deficient progeroid laminopathies (PDPL) in young people 12 months of age
Michiel, 21, Belgium. Photo courtesy of The Progeria Research Foundation.
IMPORTANT SAFETY INFORMATION
Do not take ZOKINVY if you are taking:
WHAT IS Zokinvy® (lonafarnib)?
ZOKINVY (zoh-KIN-vee) is a prescription medicine used to treat Hutchinson-Gilford Progeria Syndrome and some types of Progeroid Laminopathies known as processing-deficient Progeroid Laminopathies. These illnesses are caused when the body makes harmful proteins called progerin and progerin-like proteins.